| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | calcium ion binding | RASGRP4 ADGRE2 VWCE LRP1B LDLR EGFEM1P CRB1 CD93 SCUBE1 FBN2 SCUBE2 ADGRE4P LRP2 UMOD LTBP1 LTBP4 FBN3 NOTCH4 PROS1 | 2.37e-07 | 749 | 126 | 19 | GO:0005509 |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 2.59e-06 | 16 | 126 | 4 | GO:0005041 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 8.32e-06 | 21 | 126 | 4 | GO:0030228 | |
| GeneOntologyMolecularFunction | cargo receptor activity | 2.02e-04 | 85 | 126 | 5 | GO:0038024 | |
| GeneOntologyMolecularFunction | growth factor binding | 4.70e-04 | 156 | 126 | 6 | GO:0019838 | |
| GeneOntologyMolecularFunction | transforming growth factor beta binding | 5.74e-04 | 26 | 126 | 3 | GO:0050431 | |
| GeneOntologyMolecularFunction | ubiquitin protein ligase activity | 5.96e-04 | 372 | 126 | 9 | GO:0061630 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein ligase activity | 9.61e-04 | 398 | 126 | 9 | GO:0061659 | |
| GeneOntologyCellularComponent | microfibril | 8.63e-07 | 13 | 126 | 4 | GO:0001527 | |
| GeneOntologyCellularComponent | external encapsulating structure | COL6A6 MUC5B PKHD1L1 FBN2 OTOGL GLG1 AHSG LTBP1 ALB LOXL3 ADAMTS14 USH2A LTBP4 FBN3 | 4.38e-05 | 658 | 126 | 14 | GO:0030312 |
| GeneOntologyCellularComponent | extracellular matrix | COL6A6 MUC5B FBN2 OTOGL GLG1 AHSG LTBP1 ALB LOXL3 ADAMTS14 USH2A LTBP4 FBN3 | 1.68e-04 | 656 | 126 | 13 | GO:0031012 |
| MousePheno | small alisphenoid bone | 3.07e-05 | 9 | 102 | 3 | MP:0004459 | |
| MousePheno | absent paraxial mesoderm | 3.07e-05 | 9 | 102 | 3 | MP:0012184 | |
| MousePheno | decreased circulating transferrin level | 4.36e-05 | 10 | 102 | 3 | MP:0011894 | |
| Domain | EGF_CA | ADGRE2 VWCE LRP1B LDLR CRB1 CD93 SCUBE1 FBN2 SCUBE2 ADGRE4P LRP2 UMOD LTBP1 LTBP4 FBN3 NOTCH4 PROS1 | 5.97e-20 | 99 | 120 | 17 | PS01187 |
| Domain | ASX_HYDROXYL | ADGRE2 VWCE LRP1B LDLR CRB1 CD93 SCUBE1 FBN2 SCUBE2 ADGRE4P LRP2 UMOD LTBP1 LTBP4 FBN3 NOTCH4 PROS1 | 7.16e-20 | 100 | 120 | 17 | PS00010 |
| Domain | EGF_CA | ADGRE2 VWCE LRP1B LDLR CD93 SCUBE1 FBN2 SCUBE2 ADGRE4P LRP2 UMOD LTBP1 LTBP4 FBN3 NOTCH4 PROS1 | 1.99e-19 | 86 | 120 | 16 | PF07645 |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | ADGRE2 VWCE LRP1B LDLR CRB1 CD93 SCUBE1 FBN2 SCUBE2 ADGRE4P LRP2 UMOD LTBP1 LTBP4 FBN3 NOTCH4 PROS1 | 2.04e-19 | 106 | 120 | 17 | IPR000152 |
| Domain | Growth_fac_rcpt_ | ELAPOR2 RSPO4 ADGRE2 VWCE LRP1B LDLR CRB1 CD93 SCUBE1 FBN2 SCUBE2 LRP2 UMOD LTBP1 C9 LTBP4 FBN3 NOTCH4 PROS1 | 3.03e-19 | 156 | 120 | 19 | IPR009030 |
| Domain | EGF_Ca-bd_CS | ADGRE2 VWCE LRP1B LDLR CRB1 CD93 SCUBE1 FBN2 SCUBE2 LRP2 UMOD LTBP1 LTBP4 FBN3 NOTCH4 PROS1 | 1.54e-18 | 97 | 120 | 16 | IPR018097 |
| Domain | EGF-like_Ca-bd_dom | ADGRE2 VWCE LRP1B LDLR CRB1 CD93 SCUBE1 FBN2 SCUBE2 ADGRE4P LRP2 UMOD LTBP1 LTBP4 FBN3 NOTCH4 PROS1 | 3.28e-18 | 124 | 120 | 17 | IPR001881 |
| Domain | EGF | ADGRE2 VWCE LRP1B LDLR CRB1 CD93 SCUBE1 FBN2 MALRD1 SCUBE2 ADGRE4P BRINP2 LRP2 LRP6 UMOD LTBP1 LTBP4 FBN3 NOTCH4 PROS1 | 4.24e-17 | 235 | 120 | 20 | SM00181 |
| Domain | EGF_3 | ADGRE2 VWCE LRP1B LDLR CRB1 CD93 SCUBE1 FBN2 MALRD1 SCUBE2 ADGRE4P LRP2 LRP6 UMOD LTBP1 C9 LTBP4 FBN3 NOTCH4 PROS1 | 4.24e-17 | 235 | 120 | 20 | PS50026 |
| Domain | EGF_CA | ADGRE2 VWCE LRP1B LDLR CRB1 CD93 SCUBE1 FBN2 SCUBE2 LRP2 UMOD LTBP1 LTBP4 FBN3 NOTCH4 PROS1 | 7.02e-17 | 122 | 120 | 16 | SM00179 |
| Domain | EGF-like_dom | ADGRE2 VWCE LRP1B LDLR CRB1 CD93 SCUBE1 FBN2 MALRD1 SCUBE2 ADGRE4P LRP2 LRP6 UMOD LTBP1 C9 LTBP4 FBN3 NOTCH4 PROS1 | 1.32e-16 | 249 | 120 | 20 | IPR000742 |
| Domain | EGF_1 | ADGRE2 VWCE LRP1B LDLR CRB1 SCUBE1 FBN2 MALRD1 SCUBE2 LRP2 LRP6 UMOD LTBP1 C9 USH2A LTBP4 FBN3 NOTCH4 PROS1 | 3.24e-15 | 255 | 120 | 19 | PS00022 |
| Domain | EGF-like_CS | ADGRE2 VWCE LRP1B LDLR CRB1 CD93 SCUBE1 FBN2 MALRD1 SCUBE2 LRP2 LRP6 UMOD LTBP1 C9 LTBP4 FBN3 NOTCH4 PROS1 | 4.96e-15 | 261 | 120 | 19 | IPR013032 |
| Domain | EGF_2 | ADGRE2 VWCE LRP1B LDLR CRB1 CD93 SCUBE1 FBN2 MALRD1 SCUBE2 LRP2 LRP6 UMOD LTBP1 C9 LTBP4 FBN3 NOTCH4 PROS1 | 6.55e-15 | 265 | 120 | 19 | PS01186 |
| Domain | cEGF | 3.25e-12 | 26 | 120 | 8 | PF12662 | |
| Domain | cEGF | 3.25e-12 | 26 | 120 | 8 | IPR026823 | |
| Domain | EGF | LRP1B CRB1 CD93 MALRD1 SCUBE2 LRP2 LRP6 UMOD LTBP1 FBN3 NOTCH4 PROS1 | 2.97e-11 | 126 | 120 | 12 | PF00008 |
| Domain | TB | 5.59e-08 | 7 | 120 | 4 | PF00683 | |
| Domain | - | 1.11e-07 | 8 | 120 | 4 | 3.90.290.10 | |
| Domain | LDLR_class-A_CS | 1.99e-07 | 40 | 120 | 6 | IPR023415 | |
| Domain | TB_dom | 1.99e-07 | 9 | 120 | 4 | IPR017878 | |
| Domain | TB | 1.99e-07 | 9 | 120 | 4 | PS51364 | |
| Domain | Ldl_recept_a | 4.12e-07 | 45 | 120 | 6 | PF00057 | |
| Domain | - | 4.71e-07 | 46 | 120 | 6 | 4.10.400.10 | |
| Domain | LDLRA_1 | 6.11e-07 | 48 | 120 | 6 | PS01209 | |
| Domain | LDrepeatLR_classA_rpt | 6.92e-07 | 49 | 120 | 6 | IPR002172 | |
| Domain | LDLa | 6.92e-07 | 49 | 120 | 6 | SM00192 | |
| Domain | LDLRA_2 | 6.92e-07 | 49 | 120 | 6 | PS50068 | |
| Domain | Ldl_recept_b | 1.54e-06 | 14 | 120 | 4 | PF00058 | |
| Domain | LDLRB | 1.54e-06 | 14 | 120 | 4 | PS51120 | |
| Domain | LY | 2.09e-06 | 15 | 120 | 4 | SM00135 | |
| Domain | LDLR_classB_rpt | 2.09e-06 | 15 | 120 | 4 | IPR000033 | |
| Domain | hEGF | 2.95e-05 | 28 | 120 | 4 | PF12661 | |
| Domain | EGF_dom | 5.45e-05 | 12 | 120 | 3 | IPR024731 | |
| Domain | EGF_3 | 5.45e-05 | 12 | 120 | 3 | PF12947 | |
| Domain | - | 1.12e-04 | 39 | 120 | 4 | 2.120.10.30 | |
| Domain | FBN | 1.22e-04 | 3 | 120 | 2 | IPR011398 | |
| Domain | - | DPF1 ZNF521 COP1 PCGF3 RNF157 TRIM33 PYGO2 RNFT1 DZIP3 UBR3 ZFYVE26 | 1.51e-04 | 449 | 120 | 11 | 3.30.40.10 |
| Domain | Znf_RING/FYVE/PHD | DPF1 ZNF521 COP1 PCGF3 RNF157 TRIM33 PYGO2 RNFT1 DZIP3 UBR3 ZFYVE26 | 1.83e-04 | 459 | 120 | 11 | IPR013083 |
| Domain | zf-C2H2_6 | 1.95e-04 | 314 | 120 | 9 | PF13912 | |
| Domain | 6-blade_b-propeller_TolB-like | 2.15e-04 | 46 | 120 | 4 | IPR011042 | |
| Domain | ALBUMIN | 2.44e-04 | 4 | 120 | 2 | SM00103 | |
| Domain | Serum_albumin_N | 2.44e-04 | 4 | 120 | 2 | IPR014760 | |
| Domain | LamGL | 2.44e-04 | 4 | 120 | 2 | SM00560 | |
| Domain | Serum_albumin_CS | 2.44e-04 | 4 | 120 | 2 | IPR020857 | |
| Domain | LamG-like | 2.44e-04 | 4 | 120 | 2 | IPR006558 | |
| Domain | ALBUMIN_2 | 2.44e-04 | 4 | 120 | 2 | PS51438 | |
| Domain | ALBUMIN_1 | 2.44e-04 | 4 | 120 | 2 | PS00212 | |
| Domain | Serum_albumin | 2.44e-04 | 4 | 120 | 2 | PF00273 | |
| Domain | Serum_albumin-like | 4.04e-04 | 5 | 120 | 2 | IPR020858 | |
| Domain | Ephrin_rec_like | 5.37e-04 | 25 | 120 | 3 | SM01411 | |
| Domain | Tyr-kin_ephrin_A/B_rcpt-like | 5.37e-04 | 25 | 120 | 3 | IPR011641 | |
| Domain | GDNF | 6.04e-04 | 6 | 120 | 2 | PF02351 | |
| Domain | GDNF | 6.04e-04 | 6 | 120 | 2 | SM00907 | |
| Domain | GDNF/GAS1 | 6.04e-04 | 6 | 120 | 2 | IPR016017 | |
| Domain | ALB/AFP/VDB | 6.04e-04 | 6 | 120 | 2 | IPR000264 | |
| Domain | VWC | 7.54e-04 | 28 | 120 | 3 | PF00093 | |
| Domain | TSP1 | 8.11e-04 | 65 | 120 | 4 | SM00209 | |
| Domain | TSP1_rpt | 8.11e-04 | 65 | 120 | 4 | IPR000884 | |
| Domain | TSP1 | 8.11e-04 | 65 | 120 | 4 | PS50092 | |
| Domain | Notch_dom | 8.42e-04 | 7 | 120 | 2 | IPR000800 | |
| Domain | ZnF_UBR1 | 8.42e-04 | 7 | 120 | 2 | SM00396 | |
| Domain | ZF_UBR | 8.42e-04 | 7 | 120 | 2 | PS51157 | |
| Domain | Notch | 8.42e-04 | 7 | 120 | 2 | PF00066 | |
| Domain | zf-UBR | 8.42e-04 | 7 | 120 | 2 | PF02207 | |
| Domain | Znf_UBR | 8.42e-04 | 7 | 120 | 2 | IPR003126 | |
| Domain | NL | 8.42e-04 | 7 | 120 | 2 | SM00004 | |
| Domain | Znf_RING | 1.22e-03 | 326 | 120 | 8 | IPR001841 | |
| Domain | ZINC_FINGER_C2H2_1 | ZNF597 ZNF765 ZNF536 ZNF845 TUT4 ZNF211 ZNF521 MECOM ZBTB1 GZF1 ZNF660 ZNF608 ZNF197 | 1.47e-03 | 777 | 120 | 13 | PS00028 |
| Domain | VWFC_1 | 1.58e-03 | 36 | 120 | 3 | PS01208 | |
| Domain | MAC_perforin | 1.78e-03 | 10 | 120 | 2 | IPR001862 | |
| Domain | Znf_C2H2-like | ZNF597 ZNF765 ZNF536 ZNF845 ZNF211 ZNF521 MECOM ZBTB1 GZF1 ZNF660 ZNF608 ZNF197 ZNF638 | 1.82e-03 | 796 | 120 | 13 | IPR015880 |
| Domain | VWFC_2 | 1.85e-03 | 38 | 120 | 3 | PS50184 | |
| Domain | VWC | 1.85e-03 | 38 | 120 | 3 | SM00214 | |
| Domain | LAM_G_DOMAIN | 1.85e-03 | 38 | 120 | 3 | PS50025 | |
| Domain | Znf_C2H2 | ZNF597 ZNF765 ZNF536 ZNF845 ZNF211 ZNF521 MECOM ZBTB1 GZF1 ZNF660 ZNF608 ZNF197 ZNF638 | 2.01e-03 | 805 | 120 | 13 | IPR007087 |
| Domain | ZnF_C2H2 | ZNF597 ZNF765 ZNF536 ZNF845 ZNF211 ZNF521 MECOM ZBTB1 GZF1 ZNF660 ZNF608 ZNF197 ZNF638 | 2.07e-03 | 808 | 120 | 13 | SM00355 |
| Domain | Laminin_G_2 | 2.15e-03 | 40 | 120 | 3 | PF02210 | |
| Domain | Ephrin_rec_like | 2.17e-03 | 11 | 120 | 2 | PF07699 | |
| Domain | MACPF | 2.17e-03 | 11 | 120 | 2 | PF01823 | |
| Domain | VWF_dom | 2.47e-03 | 42 | 120 | 3 | IPR001007 | |
| Domain | MACPF | 2.59e-03 | 12 | 120 | 2 | IPR020864 | |
| Domain | MACPF | 2.59e-03 | 12 | 120 | 2 | SM00457 | |
| Domain | ZF_RING_1 | 2.76e-03 | 291 | 120 | 7 | PS00518 | |
| Domain | LamG | 2.83e-03 | 44 | 120 | 3 | SM00282 | |
| Domain | ZF_RING_2 | 3.15e-03 | 298 | 120 | 7 | PS50089 | |
| Domain | zf-C3HC4 | 3.20e-03 | 223 | 120 | 6 | PF00097 | |
| Domain | - | 3.29e-03 | 95 | 120 | 4 | 2.60.120.200 | |
| Domain | ZF_PHD_2 | 3.29e-03 | 95 | 120 | 4 | PS50016 | |
| Domain | ZF_PHD_1 | 3.42e-03 | 96 | 120 | 4 | PS01359 | |
| Domain | TIL_dom | 3.54e-03 | 14 | 120 | 2 | IPR002919 | |
| Domain | RING | 3.58e-03 | 305 | 120 | 7 | SM00184 | |
| Domain | ZINC_FINGER_C2H2_2 | ZNF597 ZNF765 ZNF536 ZNF845 ZNF211 ZNF521 MECOM ZBTB1 GZF1 ZNF660 ZNF608 ZNF197 | 4.19e-03 | 775 | 120 | 12 | PS50157 |
| Domain | - | ZNF597 ZNF765 ZNF536 ZNF845 ZNF211 ZNF521 MECOM ZBTB1 GZF1 ZNF660 ZNF197 | 4.35e-03 | 679 | 120 | 11 | 3.30.160.60 |
| Domain | zf-C2H2 | ZNF597 ZNF765 ZNF536 ZNF845 ZNF211 ZNF521 MECOM ZBTB1 GZF1 ZNF660 ZNF197 | 5.06e-03 | 693 | 120 | 11 | PF00096 |
| Domain | Znf_C2H2/integrase_DNA-bd | ZNF597 ZNF765 ZNF536 ZNF845 ZNF211 ZNF521 MECOM ZBTB1 GZF1 ZNF660 ZNF197 | 5.11e-03 | 694 | 120 | 11 | IPR013087 |
| Domain | Laminin_G | 6.17e-03 | 58 | 120 | 3 | IPR001791 | |
| Domain | ARM-type_fold | 6.32e-03 | 339 | 120 | 7 | IPR016024 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 6.03e-06 | 44 | 84 | 5 | M26969 | |
| Pathway | WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE | 1.35e-05 | 25 | 84 | 4 | M39713 | |
| Pathway | WP_COMPLEMENT_SYSTEM | 2.26e-05 | 96 | 84 | 6 | M39581 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 6.67e-05 | 37 | 84 | 4 | M27134 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 8.23e-05 | 39 | 84 | 4 | MM14601 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | DPF1 TNPO1 ZNF536 SOBP ZNF521 MECOM PCGF3 SORT1 TRIM33 PYGO2 ZNF608 ASXL3 ALB | 6.11e-10 | 351 | 127 | 13 | 38297188 |
| Pubmed | FLNA ZNF536 UBR4 APC MECOM ZDBF2 ZBTB1 ZNF608 ATF7IP2 LRP2 TMF1 ARHGAP21 | 4.81e-08 | 418 | 127 | 12 | 34709266 | |
| Pubmed | DPF1 ZNF536 SOBP CNOT10 UBR4 ZNF521 COP1 MECOM USP46 EDC4 PCGF3 ZBTB1 TRIM33 FBN2 BBX PYGO2 ZNF608 ZNF638 LRP2 LRP6 USP54 | 5.36e-08 | 1429 | 127 | 21 | 35140242 | |
| Pubmed | 1.90e-07 | 4 | 127 | 3 | 12429738 | ||
| Pubmed | MESD is essential for apical localization of megalin/LRP2 in the visceral endoderm. | 9.67e-07 | 21 | 127 | 4 | 21337463 | |
| Pubmed | 1.65e-06 | 7 | 127 | 3 | 29431745 | ||
| Pubmed | FLII CNST UBR4 BACH1 APC ZNF521 REV3L LRP1B ZBED5 TRIM33 ZNF660 ZNF197 LRP2 PDZD8 PRKDC USP54 ARHGAP21 | 4.63e-06 | 1285 | 127 | 17 | 35914814 | |
| Pubmed | Gene-smoking interactions identify several novel blood pressure loci in the Framingham Heart Study. | 5.63e-06 | 32 | 127 | 4 | 25189868 | |
| Pubmed | 7.68e-06 | 11 | 127 | 3 | 24639464 | ||
| Pubmed | 9.86e-06 | 282 | 127 | 8 | 23667531 | ||
| Pubmed | 1.02e-05 | 12 | 127 | 3 | 35132438 | ||
| Pubmed | Epithelialization of mouse ovarian tumor cells originating in the fallopian tube stroma. | 1.32e-05 | 2 | 127 | 2 | 27602775 | |
| Pubmed | An immunocompromised murine model of chronic Bartonella infection. | 1.32e-05 | 2 | 127 | 2 | 20395436 | |
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 15374947 | ||
| Pubmed | Sortilin mediates vascular calcification via its recruitment into extracellular vesicles. | 1.32e-05 | 2 | 127 | 2 | 26950419 | |
| Pubmed | Nonspecific immune responses and mechanisms of resistance to Eimeria papillata infections in mice. | 1.32e-05 | 2 | 127 | 2 | 9234770 | |
| Pubmed | Megalin/gp330 mediates uptake of albumin in renal proximal tubule. | 1.32e-05 | 2 | 127 | 2 | 8898021 | |
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 17392156 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 29899496 | ||
| Pubmed | NEDD4 Depletion Inhibits Hepatocellular Carcinoma Growth via Targeting PTEN. | 1.32e-05 | 2 | 127 | 2 | 27467187 | |
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 8140728 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 34359960 | ||
| Pubmed | Spontaneous and experimental infections in scid and scid/beige mice. | 1.32e-05 | 2 | 127 | 2 | 8320959 | |
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 20889565 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 9041176 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 23891063 | ||
| Pubmed | Epithelial microRNAs regulate gut mucosal immunity via epithelium-T cell crosstalk. | 1.32e-05 | 2 | 127 | 2 | 21278735 | |
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 32754865 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 20816088 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 19249873 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 8391609 | ||
| Pubmed | Murine granulated metrial gland cell population in beige (bg/bg) and SCID (scid/scid) genotypes. | 1.32e-05 | 2 | 127 | 2 | 8075241 | |
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 9175014 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 7523406 | ||
| Pubmed | The combined hyperlipidemia caused by impaired Wnt-LRP6 signaling is reversed by Wnt3a rescue. | 1.32e-05 | 2 | 127 | 2 | 24506864 | |
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 1639480 | ||
| Pubmed | Participation of macrophages in atherosclerotic lesion morphology in LDLr-/- mice. | 1.32e-05 | 2 | 127 | 2 | 15175354 | |
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 28714370 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 22876132 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 29941984 | ||
| Pubmed | Translocation of bacteria from the gastrointestinal tract in immunodeficient mice. | 1.32e-05 | 2 | 127 | 2 | 8709573 | |
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 8567125 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 20819705 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 8962121 | ||
| Pubmed | LRP6 protein regulates low density lipoprotein (LDL) receptor-mediated LDL uptake. | 1.32e-05 | 2 | 127 | 2 | 22128165 | |
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 20100827 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 23094018 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 26234657 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 31450893 | ||
| Pubmed | Branhamella catarrhalis pathogenesis in SCID and SCID/beige mice. Brief report. | 1.32e-05 | 2 | 127 | 2 | 8267959 | |
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 19168705 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 38558329 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 27318830 | ||
| Pubmed | Is NEDD4-1 a negative regulator of phosphatase and tensin homolog in gastric carcinogenesis? | 1.32e-05 | 2 | 127 | 2 | 23180960 | |
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 11483626 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 33712741 | ||
| Pubmed | The beneficial effect of blocking Kv1.3 in the psoriasiform SCID mouse model. | 1.32e-05 | 2 | 127 | 2 | 20739949 | |
| Pubmed | Infection of the laboratory mouse with the intracellular pathogen Ehrlichia chaffeensis. | 1.32e-05 | 2 | 127 | 2 | 9673277 | |
| Pubmed | Ubiquitination regulates PTEN nuclear import and tumor suppression. | 1.32e-05 | 2 | 127 | 2 | 17218261 | |
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 17218260 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 8418200 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 18617646 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 11924817 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 16288010 | ||
| Pubmed | Hypercholesterolemia induces T cell expansion in humanized immune mice. | 1.32e-05 | 2 | 127 | 2 | 29708512 | |
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 16844690 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 30292635 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 11158855 | ||
| Pubmed | A dosage-dependent pleiotropic role of Dicer in prostate cancer growth and metastasis. | 1.32e-05 | 2 | 127 | 2 | 23851498 | |
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 26489464 | ||
| Pubmed | Intestinal knockout of Nedd4 enhances growth of Apcmin tumors. | 1.32e-05 | 2 | 127 | 2 | 27086928 | |
| Pubmed | Evaluation of three lines of immunodeficient mice for the study of spontaneous metastatic tumors. | 1.32e-05 | 2 | 127 | 2 | 10225324 | |
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 27983532 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 19544529 | ||
| Pubmed | Stage-specific association of apolipoprotein A-I and E in developing mouse retina. | 1.68e-05 | 14 | 127 | 3 | 17389516 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | GAS1 CD109 ADGRE2 LRP1B LDLR P3H4 SORT1 FBN2 GLG1 RNFT1 CD59 LRP6 LTBP1 ARHGAP21 PROS1 | 3.41e-05 | 1201 | 127 | 15 | 35696571 |
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | 3.72e-05 | 248 | 127 | 7 | 24006456 | |
| Pubmed | 3.96e-05 | 3 | 127 | 2 | 18498243 | ||
| Pubmed | 3.96e-05 | 3 | 127 | 2 | 24293351 | ||
| Pubmed | 3.96e-05 | 3 | 127 | 2 | 26034040 | ||
| Pubmed | Live cell imaging of outward and inward vesiculation induced by the complement c5b-9 complex. | 3.96e-05 | 3 | 127 | 2 | 17644516 | |
| Pubmed | Cubilin dysfunction causes abnormal metabolism of the steroid hormone 25(OH) vitamin D(3). | 3.96e-05 | 3 | 127 | 2 | 11717447 | |
| Pubmed | 3.96e-05 | 3 | 127 | 2 | 17693663 | ||
| Pubmed | Identification of a novel family of cell-surface proteins expressed in human vascular endothelium. | 3.96e-05 | 3 | 127 | 2 | 12270931 | |
| Pubmed | Hemoglobin inhibits albumin uptake by proximal tubule cells: implications for sickle cell disease. | 3.96e-05 | 3 | 127 | 2 | 28356267 | |
| Pubmed | Loxl3 Promotes Melanoma Progression and Dissemination Influencing Cell Plasticity and Survival. | 3.96e-05 | 3 | 127 | 2 | 35267510 | |
| Pubmed | High-grade serous ovarian cancer arises from fallopian tube in a mouse model. | 3.96e-05 | 3 | 127 | 2 | 22331912 | |
| Pubmed | 3.96e-05 | 3 | 127 | 2 | 28620008 | ||
| Pubmed | 3.96e-05 | 3 | 127 | 2 | 26214492 | ||
| Pubmed | Adenoma multiplicity in irradiated Apc(Min) mice is modified by chromosome 16 segments from BALB/c. | 3.96e-05 | 3 | 127 | 2 | 12750251 | |
| Pubmed | 3.96e-05 | 3 | 127 | 2 | 7717446 | ||
| Pubmed | 3.96e-05 | 3 | 127 | 2 | 38733337 | ||
| Pubmed | 3.96e-05 | 3 | 127 | 2 | 21903772 | ||
| Pubmed | Prostate cancer induced by loss of Apc is restrained by TGFβ signaling. | 3.96e-05 | 3 | 127 | 2 | 24651496 | |
| Pubmed | 3.96e-05 | 3 | 127 | 2 | 22434720 | ||
| Pubmed | 3.96e-05 | 3 | 127 | 2 | 19011632 | ||
| Pubmed | ΔNp63α represses nuclear translocation of PTEN by inhibition of NEDD4-1 in keratinocytes. | 3.96e-05 | 3 | 127 | 2 | 23589096 | |
| Pubmed | 3.96e-05 | 3 | 127 | 2 | 21986318 | ||
| Pubmed | 3.96e-05 | 3 | 127 | 2 | 31306658 | ||
| Pubmed | Cubilin is an albumin binding protein important for renal tubular albumin reabsorption. | 3.96e-05 | 3 | 127 | 2 | 10811843 | |
| Interaction | NTN5 interactions | 1.00e-10 | 24 | 126 | 7 | int:NTN5 | |
| Interaction | FOXD4L6 interactions | 5.95e-07 | 49 | 126 | 6 | int:FOXD4L6 | |
| Interaction | ZFP41 interactions | 1.48e-06 | 57 | 126 | 6 | int:ZFP41 | |
| Interaction | PRG2 interactions | LDLR DICER1 P3H4 MTFR1L FBN2 GLG1 LRP6 PAPPA ADAMTS14 LTBP4 PROS1 | 1.80e-06 | 285 | 126 | 11 | int:PRG2 |
| Interaction | ZNF408 interactions | 3.63e-06 | 145 | 126 | 8 | int:ZNF408 | |
| Interaction | ERG interactions | 1.14e-05 | 223 | 126 | 9 | int:ERG | |
| Interaction | EGR2 interactions | 1.22e-05 | 171 | 126 | 8 | int:EGR2 | |
| Interaction | TIMP3 interactions | 2.15e-05 | 90 | 126 | 6 | int:TIMP3 | |
| Interaction | NMS interactions | 3.52e-05 | 30 | 126 | 4 | int:NMS | |
| Interaction | FBN2 interactions | 5.40e-05 | 65 | 126 | 5 | int:FBN2 | |
| Interaction | PHF21A interactions | 6.01e-05 | 343 | 126 | 10 | int:PHF21A | |
| GeneFamily | Low density lipoprotein receptors | 3.46e-07 | 13 | 87 | 4 | 634 | |
| GeneFamily | Latent transforming growth factor beta binding proteins | 1.36e-04 | 4 | 87 | 2 | 628 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF597 ZNF765 ZNF536 ZNF845 ZNF211 ZNF521 MECOM ZBTB1 GZF1 ZNF660 ZNF608 ZNF197 | 1.62e-04 | 718 | 87 | 12 | 28 |
| GeneFamily | CD molecules|Adhesion G protein-coupled receptors, subfamily E | 2.27e-04 | 5 | 87 | 2 | 915 | |
| GeneFamily | Ubiquitin protein ligase E3 component n-recognins | 4.73e-04 | 7 | 87 | 2 | 785 | |
| GeneFamily | Ring finger proteins | 2.12e-03 | 275 | 87 | 6 | 58 | |
| Coexpression | NABA_MATRISOME | CHRDL2 COL6A6 CD109 RSPO4 MUC5B VWCE CD209 EGFEM1P SCUBE1 FBN2 SCUBE2 OTOGL BRINP2 PAPPA LTBP1 LOXL3 ADAMTS14 LTBP4 | 1.82e-06 | 1008 | 127 | 18 | MM17056 |
| Coexpression | NABA_MATRISOME | CHRDL2 COL6A6 CD109 RSPO4 MUC5B VWCE CD209 SCUBE1 FBN2 SCUBE2 BRINP2 PAPPA LTBP1 LOXL3 ADAMTS14 USH2A LTBP4 FBN3 | 2.34e-06 | 1026 | 127 | 18 | M5889 |
| Coexpression | SHIN_B_CELL_LYMPHOMA_CLUSTER_7 | 8.46e-06 | 27 | 127 | 4 | M1391 | |
| Coexpression | SHIN_B_CELL_LYMPHOMA_CLUSTER_7 | 8.46e-06 | 27 | 127 | 4 | MM1135 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 4.18e-05 | 191 | 127 | 7 | MM17059 | |
| Coexpression | GSE9509_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_20MIN_UP | 4.77e-05 | 195 | 127 | 7 | M6899 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 4.92e-05 | 196 | 127 | 7 | M3008 | |
| Coexpression | NABA_CORE_MATRISOME | 5.32e-05 | 270 | 127 | 8 | MM17057 | |
| Coexpression | GSE17721_PAM3CSK4_VS_CPG_2H_BMDC_DN | 5.59e-05 | 200 | 127 | 7 | M3858 | |
| Coexpression | DESCARTES_FETAL_THYMUS_STROMAL_CELLS | 5.62e-05 | 137 | 127 | 6 | M40313 | |
| Coexpression | NABA_CORE_MATRISOME | 6.05e-05 | 275 | 127 | 8 | M5884 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | TNPO1 TUT4 APC REV3L PTEN TRIM33 BBX ZNF638 TMF1 AKAP11 PROS1 ENOX2 | 8.56e-05 | 656 | 127 | 12 | M18979 |
| Coexpression | ASTON_MAJOR_DEPRESSIVE_DISORDER_UP | 9.41e-05 | 49 | 127 | 4 | M25 | |
| Coexpression | MARTINEZ_RB1_TARGETS_DN | FLNA UNC5B GAS1 ZNF521 EDC4 SORT1 FBN2 ATF7IP2 ATP11A LTBP1 ENOX2 | 1.05e-04 | 569 | 127 | 11 | M12701 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | DPF1 ZNF536 TUT4 SOBP MECOM ZDBF2 REV3L LDLR DICER1 SORT1 SCUBE1 SCUBE2 LRP2 PAPPA DHX32 PRKDC CCDC171 ARHGAP21 | 1.40e-05 | 989 | 122 | 18 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.35e-08 | 152 | 127 | 8 | 621e9b33cd3bb1c7b7d0633069f286b203e3d9c0 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.01e-08 | 160 | 127 | 8 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.01e-08 | 160 | 127 | 8 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.95e-08 | 184 | 127 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.95e-08 | 184 | 127 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.95e-08 | 184 | 127 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.26e-08 | 192 | 127 | 8 | df1545670370fb1010c567cd059c2783eab315f7 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-myeloid-myeloid_dendritic-CD141-positive_myeloid_dendritic_cell|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.62e-07 | 158 | 127 | 7 | 4f3ea658e032555c2098d016475381c8d1071699 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.94e-07 | 160 | 127 | 7 | 6ed37d1fd0304932319d6b942502404115ff36a7 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_bronchial_vessel-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.17e-07 | 171 | 127 | 7 | 1ae4b6a25bc9c1065cf5d95998ebcc70aee21ab5 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.93e-07 | 174 | 127 | 7 | a9c6edf5c3fc119c24425f921c5566a8356c30fe | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.08e-07 | 178 | 127 | 7 | bcbdd45a2307f8aea14122fa0144b96b1f6eec48 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.08e-07 | 178 | 127 | 7 | c413861148129be1ee94f2ceb5999840217eebe5 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.71e-07 | 180 | 127 | 7 | 01f2e5d96016823482f89ba503d007d4bd88eeac | |
| ToppCell | facs-Kidney-nan-3m|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.37e-07 | 182 | 127 | 7 | 4c5d14e33ebdf117b5aa9e2f57aaa89aa51f72bf | |
| ToppCell | PBMC-Severe-Hematopoietic-HSPC-HSPC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.01e-06 | 184 | 127 | 7 | 51d0447699e3b8f01abbde83f26b748bc9f3c723 | |
| ToppCell | PBMC-Severe-Hematopoietic-HSPC-HSPC-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.01e-06 | 184 | 127 | 7 | f7b0bb45a9055ab34e98b251217f6ec38c75ca22 | |
| ToppCell | E17.5-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.01e-06 | 184 | 127 | 7 | 607b55022de21ddb6a2d75e085df76df7abf6624 | |
| ToppCell | PBMC-Severe-Hematopoietic-HSPC|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.01e-06 | 184 | 127 | 7 | 26edbf84216538b80f1ffcc079ee6e385a71fbf9 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.12e-06 | 187 | 127 | 7 | c104fbfef2d0bef64077ac721edf2379fd59d547 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Artery|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.21e-06 | 189 | 127 | 7 | c45734970036e6d28d5e3fe7c9458fae38a3f624 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Artery|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.21e-06 | 189 | 127 | 7 | b028466fcd36fdeceec752e55a24286a1cd62ae4 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.25e-06 | 190 | 127 | 7 | bf9bc57a605c7e3979bc4f7260e6fb92c3eb8690 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Artery|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.25e-06 | 190 | 127 | 7 | aed65d584ca0c25f6a8313c66b421a6618af82ea | |
| ToppCell | Children_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.29e-06 | 191 | 127 | 7 | e432c6e1ae82dddf84314ce73d2b7a991630d905 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.64e-06 | 198 | 127 | 7 | 5e781583908c4ee107d986904a646a7c6b8e3591 | |
| ToppCell | COVID-19-kidney-AQP1+PLVAP+EC|kidney / Disease (COVID-19 only), tissue and cell type | 1.64e-06 | 198 | 127 | 7 | 8689090bce9ab6e8f122426a404037e572c6713b | |
| ToppCell | wk_15-18-Mesenchymal-Fibroblast-Adventitial_fibro|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.70e-06 | 199 | 127 | 7 | 8de6d7b2067b22cb9b5f01aa56a3803aebc4406d | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.70e-06 | 199 | 127 | 7 | 8b86c69aaf60feff53aa782559cfece7342a23de | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.76e-06 | 200 | 127 | 7 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.76e-06 | 200 | 127 | 7 | b2d4e6f3e8e4da62e6b02758ab2ed8f505269f9a | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.52e-06 | 167 | 127 | 6 | c042d6cdddd0e1ddef1e3ac6f4fe23151127b0f2 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.52e-06 | 167 | 127 | 6 | 351f8de1fbdf742ac74f9099b254d515ab539bb2 | |
| ToppCell | 10x5'-lymph-node_spleen-Mast-Mast_cells|lymph-node_spleen / Manually curated celltypes from each tissue | 8.82e-06 | 168 | 127 | 6 | 650ad3ea52577887885d82457dbc04202ce3eb34 | |
| ToppCell | 10x5'-lymph-node_spleen-Mast|lymph-node_spleen / Manually curated celltypes from each tissue | 8.82e-06 | 168 | 127 | 6 | e58ffbb57c81967766755c3f6f347b158a39cb0d | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.12e-06 | 169 | 127 | 6 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | P28-Epithelial-epithelial_progenitor_cell-epithelial_progenitor_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 9.44e-06 | 170 | 127 | 6 | d0ed3a8a7ad96c05641ec409b0a69c4fb094893c | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.04e-05 | 173 | 127 | 6 | 1f16d47f5548e257e4b17f8070c5619780a9c5fd | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m-Mesenchymal|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-05 | 173 | 127 | 6 | 66f37c1437705734b20601656fa4aa1d92ca30be | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m-Mesenchymal-nan|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-05 | 173 | 127 | 6 | 649b08a409095592cccf31883be69c754411280d | |
| ToppCell | wk_15-18-Mesenchymal-Chondrocyte-intermediate_chondrocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.11e-05 | 175 | 127 | 6 | a84965d28438a4228d841b357c2cd75cf4b59a63 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.23e-05 | 178 | 127 | 6 | a107dd98a07086ed0429116095ecda60c9dbef1e | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Mucinous_Colon_Adenocarcinoma-10|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 1.27e-05 | 179 | 127 | 6 | cc079ba015326dccde955c5eafa3e4a2e40de192 | |
| ToppCell | 5'-Adult-LymphNode-Endothelial-lymphatic_endothelial-LEC6_(ADAMTS4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.27e-05 | 179 | 127 | 6 | 9fd9b136ecbcbd4e4f0d5875ede98d8d48608afb | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.27e-05 | 179 | 127 | 6 | cb38b54261a7af5ee3347e64c8aa880a77ed0763 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.35e-05 | 181 | 127 | 6 | 25915e2500430a902db37d79a749ce2990b69810 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.35e-05 | 181 | 127 | 6 | d7e04e0ca549eac6d9b1192b6578f9b54943d54f | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.39e-05 | 182 | 127 | 6 | ed6ae0fd8653f213fe29906a6a4e0729a62e1b75 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.39e-05 | 182 | 127 | 6 | 9966f42c338cbd471efa8ffc765a6ce93693aa75 | |
| ToppCell | E18.5-samps-Mesenchymal-Myofibroblast|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.43e-05 | 183 | 127 | 6 | de08f9ea02b7244d5a8788064631d10f06565337 | |
| ToppCell | Basal|World / shred by cell class for mouse tongue | 1.43e-05 | 183 | 127 | 6 | c6729a207526ff4aa48176207b9353176f631fea | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-05 | 183 | 127 | 6 | ebe369dc80c4fbf8f4dbe947147f8c47507ffb60 | |
| ToppCell | PBMC-Severe-Hematopoietic-HSPC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.48e-05 | 184 | 127 | 6 | a6169613c6493b947a176493f542368bfa935dab | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.48e-05 | 184 | 127 | 6 | e2de27cee3ea80f9b7a9a7884ceceeaa67b3214a | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.48e-05 | 184 | 127 | 6 | ab2f06906fc7a9931dfa0864ef506832b07fb93e | |
| ToppCell | COVID-19_Moderate-HSPC|World / disease group, cell group and cell class | 1.48e-05 | 184 | 127 | 6 | ccc93babe1fcdeb66b78e1d8414357877a7c45bd | |
| ToppCell | PBMC-Severe-Hematopoietic-HSPC-HSPC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.48e-05 | 184 | 127 | 6 | cc01c19180861f491a8dc16d60fabd1215fc4525 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.48e-05 | 184 | 127 | 6 | b45b1fdba13c8ed2a04a4fb3b62d8ad92785c768 | |
| ToppCell | PBMC-Severe-Hematopoietic-HSPC-HSPC-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.48e-05 | 184 | 127 | 6 | 492c680f0769ba4e651d09c2e8e5d5d271ed08aa | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.53e-05 | 185 | 127 | 6 | 6712512100ccef456d2e2bd201d0987986c92ac9 | |
| ToppCell | Control-Epithelial_alveolar-AT_2-Differentiating_AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.53e-05 | 185 | 127 | 6 | 0d2add28ac1f4fa6de7699be009bf8391badaf4c | |
| ToppCell | PND07-28-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_C|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.53e-05 | 185 | 127 | 6 | 427176ad9ab8d9511200fb0a132cfd1e835fe35c | |
| ToppCell | COVID-19-kidney-FLT1+PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.53e-05 | 185 | 127 | 6 | 673308ca0514a4d3629d61fe91e9d8fb31b72166 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.57e-05 | 186 | 127 | 6 | 4d68ee3d32f7ef884faf402ef92b31b0eb4656f1 | |
| ToppCell | Control-Epithelial-Club|World / Disease state, Lineage and Cell class | 1.57e-05 | 186 | 127 | 6 | 9798428691408e17ff2af2fe2d1b345f074d67e4 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.57e-05 | 186 | 127 | 6 | e83718fabb057100835d3357df407f283d23fe16 | |
| ToppCell | droplet-Lung-LUNG-1m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-05 | 187 | 127 | 6 | 9c9ae8725905ba0cfe407878006ed06c2480fb72 | |
| ToppCell | 15-Trachea-Epithelial-Secretory_progenitor|Trachea / Age, Tissue, Lineage and Cell class | 1.62e-05 | 187 | 127 | 6 | be9fce9e74b2f170a2067f1b31d802912a578329 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-05 | 187 | 127 | 6 | 4e553721fa5598cb211f44e3226280b7e6885484 | |
| ToppCell | Adult-Endothelial-capillary_endothelial_cell_(Cap1)-D175|Adult / Lineage, Cell type, age group and donor | 1.62e-05 | 187 | 127 | 6 | f3548817f2fded5978137bb252cb628ac199e4f6 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-05 | 187 | 127 | 6 | d36e7fc6125e7a4310499365022d38f34b757a73 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-05 | 187 | 127 | 6 | 827eae63fabf6892a82ce7779b5f395958d3d628 | |
| ToppCell | P03-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_artery|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.62e-05 | 187 | 127 | 6 | 66ebe1788d51b3e17bec6cdb219f709756b4e530 | |
| ToppCell | droplet-Lung-LUNG-1m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-05 | 187 | 127 | 6 | 9e9460e57cdc9cd0a0de2866b140e06d0bc19a8f | |
| ToppCell | droplet-Lung-1m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.67e-05 | 188 | 127 | 6 | dc52dd2957be3f40001f0a56f3d9ac9d66ea466e | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.67e-05 | 188 | 127 | 6 | 789d1be574e693d7bdd488f3c72c6df788e47b47 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.67e-05 | 188 | 127 | 6 | 4d1e5f85342ae550086609d7680e32730b78b5d2 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.67e-05 | 188 | 127 | 6 | 997dcfc4f08738ab398d8abc15e4fd2fc6619862 | |
| ToppCell | droplet-Lung-1m-Endothelial-lymphatic_endothelial|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.67e-05 | 188 | 127 | 6 | 2ef08313087e91985bcffc46c3798470cdeec49c | |
| ToppCell | droplet-Lung-1m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.67e-05 | 188 | 127 | 6 | 1f1604b6dc0a8ad0be3d9aac0bef448459c22465 | |
| ToppCell | systemic_lupus_erythematosus-flare-Hematopoietic-progenitor_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.67e-05 | 188 | 127 | 6 | c613c6c7b6de8ed514253c9f9b8622c56fcc1452 | |
| ToppCell | Mesenchymal-myofibroblast_cell|World / Lineage, Cell type, age group and donor | 1.72e-05 | 189 | 127 | 6 | 44e37f88137bb249933eb615235b2cf2ae7f3925 | |
| ToppCell | COVID_vent-Myeloid-Monocytic-SC_&_Eosinophil|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.72e-05 | 189 | 127 | 6 | 2157a2d40613f7d5ce2e7dbd266df441e449cdaf | |
| ToppCell | COVID-19_Severe-HSPC|World / disease group, cell group and cell class | 1.72e-05 | 189 | 127 | 6 | 555c0b13f1508b9e3712b36d77144e73e828bc76 | |
| ToppCell | COVID-19_Severe-HSPC|COVID-19_Severe / disease group, cell group and cell class | 1.72e-05 | 189 | 127 | 6 | 96015439971e2e5b8d6294ca5a6b873c7774e925 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.72e-05 | 189 | 127 | 6 | e82211b9dc7540e7a183be2cbcfae39fdf503949 | |
| ToppCell | Mesenchymal-airway_smooth_muscle_cell|World / Lineage, Cell type, age group and donor | 1.77e-05 | 190 | 127 | 6 | 645e56b02edc3702c7db917b8ecd5eed0decaf71 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Endothelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-05 | 190 | 127 | 6 | cb8798839c27f307955fcc94a1ee40bca95b8e99 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.77e-05 | 190 | 127 | 6 | a3c6eec6df052105ab78b7e3c78f94218d5912eb | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Endothelial-kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-05 | 190 | 127 | 6 | 5bf3d0beee69879c95265d07fba023626a7cc808 | |
| ToppCell | COPD-Epithelial-Club|COPD / Disease state, Lineage and Cell class | 1.83e-05 | 191 | 127 | 6 | c909cf5fa0e6519aa93a47d2c3fcd2ae2163cd8d | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|World / Lineage, Cell type, age group and donor | 1.83e-05 | 191 | 127 | 6 | d3733c8c4bda70c4390e5601fdda6188a64be944 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Artery|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.83e-05 | 191 | 127 | 6 | 4b3d5157344dbfbf4fab518611cd9fa37fac7bd9 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.88e-05 | 192 | 127 | 6 | 8d56e360ebc624ca4cd7f0af4f3cc599c244f134 | |
| ToppCell | COVID-19-kidney-AQP1+PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.88e-05 | 192 | 127 | 6 | 27ff3621e177e7932dd44dd6baa81551ea75a874 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.88e-05 | 192 | 127 | 6 | 29f49f00770c991b5f27e4cb701dd2d2d6cb7178 | |
| ToppCell | droplet-Kidney-nan-18m-Endothelial-kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.88e-05 | 192 | 127 | 6 | 144503af50274eaed5cf6effa892c640eab28663 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.88e-05 | 192 | 127 | 6 | ee085e04d5dcfb657522484ed20b8c1ddeccfe0c | |
| ToppCell | droplet-Kidney-nan-18m-Endothelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.88e-05 | 192 | 127 | 6 | c96736bb3a6bb052678b1b078f7823063ca69e6d | |
| ToppCell | Mesenchymal-matrix_fibroblast_2_cell|World / Lineage, Cell type, age group and donor | 1.88e-05 | 192 | 127 | 6 | a769158c49d2b208c4224d85e7ae68c85cc372ed | |
| Drug | Oxolinic acid [14698-29-4]; Down 200; 15.4uM; PC3; HT_HG-U133A | 1.60e-06 | 196 | 127 | 9 | 2103_DN | |
| Disease | attempted suicide | 9.65e-06 | 178 | 122 | 7 | EFO_0004321 | |
| Disease | connective tissue disease (implicated_via_orthology) | 5.07e-05 | 3 | 122 | 2 | DOID:65 (implicated_via_orthology) | |
| Disease | creatinine measurement, glomerular filtration rate | 1.29e-04 | 117 | 122 | 5 | EFO_0004518, EFO_0005208 | |
| Disease | familial meningioma (is_implicated_in) | 2.52e-04 | 6 | 122 | 2 | DOID:4586 (is_implicated_in) | |
| Disease | MENINGIOMA, FAMILIAL, SUSCEPTIBILITY TO | 2.52e-04 | 6 | 122 | 2 | 607174 | |
| Disease | Familial meningioma | 2.52e-04 | 6 | 122 | 2 | cv:C3551915 | |
| Disease | Familial meningioma | 2.52e-04 | 6 | 122 | 2 | C1333989 | |
| Disease | fatty liver disease (implicated_via_orthology) | 2.85e-04 | 31 | 122 | 3 | DOID:9452 (implicated_via_orthology) | |
| Disease | joint hypermobility measurement | 3.44e-04 | 33 | 122 | 3 | EFO_0007905 | |
| Disease | pack-years measurement, systolic blood pressure | 3.76e-04 | 34 | 122 | 3 | EFO_0006335, EFO_0006526 | |
| Disease | endometrial cancer (is_marker_for) | 4.10e-04 | 35 | 122 | 3 | DOID:1380 (is_marker_for) | |
| Disease | Malignant neoplasm of breast | FLNA GFRAL UBR4 CD109 MECOM PTEN NEDD4 OTOGL ANKRD30A ZFYVE26 DHX32 USP54 NOTCH4 | 5.15e-04 | 1074 | 122 | 13 | C0006142 |
| Disease | hemangiopericytoma (is_marker_for) | 5.99e-04 | 9 | 122 | 2 | DOID:264 (is_marker_for) | |
| Disease | Kunitz-type protease inhibitor 2 measurement | 7.47e-04 | 10 | 122 | 2 | EFO_0008200 | |
| Disease | Acute kidney injury | 8.34e-04 | 101 | 122 | 4 | C2609414 | |
| Disease | Acute Kidney Insufficiency | 8.34e-04 | 101 | 122 | 4 | C1565662 | |
| Disease | Kidney Failure, Acute | 8.34e-04 | 101 | 122 | 4 | C0022660 | |
| Disease | hepatocellular carcinoma (is_implicated_in) | 9.55e-04 | 181 | 122 | 5 | DOID:684 (is_implicated_in) | |
| Disease | familial hyperlipidemia (implicated_via_orthology) | 1.09e-03 | 12 | 122 | 2 | DOID:1168 (implicated_via_orthology) | |
| Disease | lower face morphology measurement | 1.11e-03 | 109 | 122 | 4 | EFO_0010948 | |
| Disease | Fulminant Hepatic Failure with Cerebral Edema | 1.28e-03 | 13 | 122 | 2 | C0751197 | |
| Disease | Hepatic Stupor | 1.28e-03 | 13 | 122 | 2 | C0751198 | |
| Disease | Hepatic Encephalopathy | 1.28e-03 | 13 | 122 | 2 | C0019151 | |
| Disease | Hepatic Coma | 1.28e-03 | 13 | 122 | 2 | C0019147 | |
| Disease | gallbladder cancer (is_implicated_in) | 1.28e-03 | 13 | 122 | 2 | DOID:3121 (is_implicated_in) | |
| Disease | Metabolic Bone Disorder | 1.49e-03 | 14 | 122 | 2 | C0005944 | |
| Disease | Hamman-Rich syndrome | 1.49e-03 | 14 | 122 | 2 | C0085786 | |
| Disease | Respiratory Distress Syndrome, Adult | 1.55e-03 | 55 | 122 | 3 | C0035222 | |
| Disease | memory performance | 1.60e-03 | 409 | 122 | 7 | EFO_0004874 | |
| Disease | optic disc size measurement | 1.66e-03 | 205 | 122 | 5 | EFO_0004832 | |
| Disease | Osteopenia | 1.72e-03 | 15 | 122 | 2 | C0029453 | |
| Disease | lobe attachment | 1.73e-03 | 207 | 122 | 5 | EFO_0007667 | |
| Disease | Malignant Neoplasms | 2.00e-03 | 128 | 122 | 4 | C0006826 | |
| Disease | Sarcomatoid Renal Cell Carcinoma | 2.00e-03 | 128 | 122 | 4 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 2.00e-03 | 128 | 122 | 4 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 2.00e-03 | 128 | 122 | 4 | C1266044 | |
| Disease | Papillary Renal Cell Carcinoma | 2.00e-03 | 128 | 122 | 4 | C1306837 | |
| Disease | Renal Cell Carcinoma | 2.00e-03 | 128 | 122 | 4 | C0007134 | |
| Disease | cup-to-disc ratio measurement | 2.12e-03 | 430 | 122 | 7 | EFO_0006939 | |
| Disease | body weight | ACP7 ZNF521 MECOM LRP1B CRB1 FBN2 DNAH12 ASXL3 ZNF638 PAPPA LTBP1 ADAMTS14 CCDC171 | 2.19e-03 | 1261 | 122 | 13 | EFO_0004338 |
| Disease | Lipidemias | 2.21e-03 | 17 | 122 | 2 | C1706412 | |
| Disease | Hyperlipidemia | 2.21e-03 | 17 | 122 | 2 | C0020473 | |
| Disease | neuroticism measurement, cognitive function measurement | 2.49e-03 | 566 | 122 | 8 | EFO_0007660, EFO_0008354 | |
| Disease | Coronary Arteriosclerosis | 2.50e-03 | 65 | 122 | 3 | C0010054 | |
| Disease | Coronary Artery Disease | 2.50e-03 | 65 | 122 | 3 | C1956346 | |
| Disease | interstitial lung disease | 2.72e-03 | 67 | 122 | 3 | EFO_0004244 | |
| Disease | Usual Interstitial Pneumonia | 2.77e-03 | 19 | 122 | 2 | C4721509 | |
| Disease | Hamman-Rich Disease | 2.77e-03 | 19 | 122 | 2 | C4721508 | |
| Disease | blood urea nitrogen measurement | 2.80e-03 | 452 | 122 | 7 | EFO_0004741 | |
| Disease | cortisol measurement | 3.07e-03 | 20 | 122 | 2 | EFO_0005843 | |
| Disease | seborrheic dermatitis | 3.07e-03 | 20 | 122 | 2 | EFO_1000764 | |
| Disease | Familial Idiopathic Pulmonary Fibrosis | 3.07e-03 | 20 | 122 | 2 | C4721952 | |
| Disease | chin morphology measurement | 3.09e-03 | 70 | 122 | 3 | EFO_0007842 | |
| Disease | anorexia nervosa | 3.09e-03 | 70 | 122 | 3 | MONDO_0005351 | |
| Disease | metabolite measurement, diet measurement | 3.21e-03 | 71 | 122 | 3 | EFO_0004725, EFO_0008111 | |
| Disease | monocyte count | ARHGAP42 TNPO1 PROK2 RASGRP4 MECOM GC LYST BBX ZNF608 GLG1 PRKDC MN1 NOTCH4 | 3.25e-03 | 1320 | 122 | 13 | EFO_0005091 |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 3.38e-03 | 148 | 122 | 4 | C0279702 | |
| Disease | Idiopathic Pulmonary Fibrosis | 3.38e-03 | 21 | 122 | 2 | C1800706 | |
| Disease | Nephritis, Tubulointerstitial | 3.38e-03 | 21 | 122 | 2 | C0041349 | |
| Disease | cholangiocarcinoma (is_implicated_in) | 3.71e-03 | 22 | 122 | 2 | DOID:4947 (is_implicated_in) | |
| Disease | Splenomegaly | 3.71e-03 | 22 | 122 | 2 | C0038002 | |
| Disease | remission, hepatitis C virus infection | 4.05e-03 | 23 | 122 | 2 | EFO_0003047, EFO_0009785 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DNSVASIEAKANVCC | 546 | Q8NHY2 | |
| DSESCSAREQECEVK | 511 | O14867 | |
| LDEVLEANCCDSAVD | 56 | Q9Y2D5 | |
| IKSNERCCSFDGDAD | 266 | O95394 | |
| TCVADESAENCDKSL | 76 | P02768 | |
| TETDCNDKCSHNTEV | 866 | Q8WY36 | |
| TTKDACFASAVECLQ | 1546 | Q96Q42 | |
| DDINECATLSKVSCG | 66 | Q9UHX3 | |
| DASNEEKACNELDST | 471 | Q6TFL3 | |
| KSCSLCGTSENDDQL | 326 | Q92782 | |
| DDFVIDCCTSLVASD | 2326 | Q7Z2Y8 | |
| ADTACKADDSVVSQD | 666 | Q9H116 | |
| HDSSEKCEDINECET | 46 | Q86SQ3 | |
| LDSSQLDCVDVDECQ | 336 | Q9NPY3 | |
| DTESLCETVSQKDVC | 686 | Q9BXX3 | |
| LQSQKELCSVTAEDC | 31 | Q9UKA4 | |
| ICKKSAASCSRDEEQ | 376 | Q9NNX6 | |
| ADCKTAVNCSSDFDA | 36 | P13987 | |
| AVNCSSDFDACLITK | 41 | P13987 | |
| EQCIADKSIADCVEA | 1551 | Q9UPY3 | |
| SKSILASCEFDCVDE | 491 | Q7L7V1 | |
| TADGKNCVDTNECLS | 1921 | Q75N90 | |
| ADSSNADELELKCSC | 2201 | Q9C0F0 | |
| DDAQKCELICQSADT | 641 | Q8WXS8 | |
| DCLQRDGTTAASCKD | 5231 | Q9HC84 | |
| SDEQVSICLECNSSK | 151 | Q3KNV8 | |
| EKQVICLSGDDSSTC | 76 | Q6P2E9 | |
| CEDCDQLFESKAELA | 211 | Q03112 | |
| CSNADLDDCTRHESK | 291 | Q6ZNF0 | |
| SFCLEDTECQEDVSK | 636 | P58215 | |
| KCSDFCQDDLADDDI | 1181 | Q13045 | |
| DCGDNSDELDCKVST | 2576 | Q9NZR2 | |
| SDELDCKVSTCATVE | 2581 | Q9NZR2 | |
| DCADASDEANCDKKT | 3461 | Q9NZR2 | |
| ADGSDERNCETSCSK | 3541 | Q9NZR2 | |
| TCNDDSLLDDSCKLT | 4206 | Q9NZR2 | |
| AAAVSCTESDEGAKC | 71 | P43366 | |
| DCTNELSNSCKTRDD | 506 | P46934 | |
| EKESCASRLCASNQD | 501 | Q16206 | |
| HLACQEDLSCEESDS | 366 | Q14153 | |
| LSAAKDQCEDIDECQ | 1111 | Q14766 | |
| QEKCLAETSVCGATD | 881 | Q8NEN9 | |
| CSEDELLEKCIQSFD | 56 | Q8TDF6 | |
| CASLSSAKCSEDDDE | 231 | Q9H4S2 | |
| LEKICEDFTSETCNS | 2566 | Q6ZR08 | |
| DHNVDCSDKSDELDC | 1346 | O75581 | |
| ACSSSEEDDCVSLSK | 221 | Q9H019 | |
| AKCASNSESDNAACE | 226 | A0A087WXM9 | |
| EDCDCAQDENCKSTK | 126 | P54826 | |
| DGSDEKNCNSTETCQ | 1136 | P98164 | |
| LANDSKTCEDIDECD | 1381 | P98164 | |
| LANCDISKIGDENCD | 411 | Q13219 | |
| SECRIKCEDSDASQG | 1436 | Q13219 | |
| CQACKDEASEQSDEE | 171 | Q6WN34 | |
| DCERSCEADILKNTS | 256 | Q86Y13 | |
| CKDDSQFSEEGSSEC | 326 | A8MWY0 | |
| KCSQEDHCLTSDLED | 51 | Q9NZU5 | |
| EVNDDQDAILCEASC | 336 | Q9BRQ0 | |
| DAAVITGACDKDSQC | 26 | Q9HC23 | |
| EESSCEKGCQVTSEQ | 666 | Q6PIJ6 | |
| CIAKESVCDSRQDCS | 446 | Q5VYJ5 | |
| KLCDFVNDCADNSDE | 1281 | Q5VYJ5 | |
| NTDENECGSSCTFEK | 1511 | Q5VYJ5 | |
| EDELICSNKSCSNGA | 1976 | Q5VYJ5 | |
| QLHCSDEISSLCAEE | 1006 | Q92896 | |
| NSEVKLSSCDLCSDV | 1396 | Q6YHK3 | |
| KQEEDESCAAAEALT | 336 | Q6ZUS6 | |
| TLSKQDLTCSGSDDC | 261 | Q6UXV0 | |
| LDGKCSISCDDETVN | 841 | Q8IZS8 | |
| TIKETTGNIACEDCS | 981 | Q8IZS8 | |
| CASCEAEDLDALQAA | 106 | A8K830 | |
| TDCVAKEATEAAKCN | 206 | P02765 | |
| SKAEISCTDNQDGTC | 1906 | P21333 | |
| EKDESLCLSSSCEGA | 106 | Q92771 | |
| SNNCADDILKTDECS | 241 | Q5U623 | |
| SEEAEDSQCCSFKLL | 1201 | Q99698 | |
| EDAFISSCESAKTVC | 2161 | Q99698 | |
| ACVDINECDEAEAAS | 1571 | Q8N2S1 | |
| RDCKKSTSSQLDCVD | 461 | A8MUX0 | |
| KSDNCAELSEATDDA | 2591 | Q8NDH2 | |
| DGKNCVDHDECTTTN | 611 | P35556 | |
| EDCVDINECSLSDNL | 1196 | P35556 | |
| KDFSKDNDCSCSDTA | 46 | P82279 | |
| DNDCSCSDTANNLDK | 51 | P82279 | |
| CVEENTLECSAKNGS | 71 | Q0D2K5 | |
| TKMEEASDTCEADCL | 556 | Q8IWY4 | |
| LTDEKSCQDVDECSL | 356 | Q9NQ36 | |
| NNESCTLSCEVAAGE | 71 | Q6PJW8 | |
| DVTASVCNSSKVDCE | 981 | A6NMZ7 | |
| TETNKAEQCCEETAS | 246 | P02748 | |
| YIASCVNDLCKTDDD | 341 | Q3ZCN5 | |
| ENGSLCDQEIDSICS | 291 | P60484 | |
| DSELGSCCSEAVKSA | 1196 | Q10571 | |
| CVAASRCDDKSVENC | 461 | Q13835 | |
| GLDVTNCKACDCDTA | 786 | O75445 | |
| SECDATAKNKNECSL | 446 | Q99523 | |
| EKSEQVCTSCEDNAS | 211 | Q9UPN9 | |
| AEDEVSDNSAECVVC | 266 | Q96PX1 | |
| EEAATCQVLSESRKC | 176 | Q2I0M5 | |
| DATKTDAESDCQSVA | 691 | A6NI28 | |
| LKSKSCEDIDECSEN | 236 | P07225 | |
| SCEENLDDCIAATCA | 351 | Q99466 | |
| TCSSEGELVCKENDC | 281 | Q9C0B6 | |
| SAHCTENKADICAVD | 596 | P25054 | |
| AASDSECCNINLDTE | 891 | Q9NRU3 | |
| AECCIAANKGTSEQE | 396 | Q9H9A5 | |
| CLCHTVQVKDDDSVD | 476 | P98196 | |
| CEECDEAFSFKSNLE | 441 | Q96IR2 | |
| TQECVSDSECADNLK | 46 | Q14508 | |
| QKLTESCCSSDAFER | 311 | P82094 | |
| VAASKRQCSDVDDIC | 361 | Q5M7Z0 | |
| CECDVSEKEFSQTSN | 986 | O14709 | |
| TCEECSIDEDCKSNN | 296 | P07911 | |
| SFCVQQAEDCLSEKS | 1761 | O60673 | |
| CELCQSCLSDVDTEI | 781 | Q9UJ98 | |
| SELESVKENNCASNC | 766 | A7XYQ1 | |
| AESLQCKVDCEANLT | 266 | Q92791 | |
| CESCDKQFTSVDDLQ | 696 | Q96K83 | |
| EGSDQESEKDNSQCC | 21 | Q6AZW8 | |
| ADGSVSCKRTDCVDS | 596 | Q96DN2 | |
| EDITNILSKCCESAS | 256 | P02774 | |
| ILSKCCESASEDCMA | 261 | P02774 | |
| SCINTECIDIEDKSC | 1561 | Q9HCK1 | |
| KEGSSSQNADSCEIC | 101 | Q13398 | |
| CDVEKDASHSTQITC | 86 | Q86WI1 | |
| RDCSGTLLDSKNCTD | 336 | Q8IZJ1 | |
| EAACSAFATLEEEAC | 506 | Q92973 | |
| ADEKSLGTIQQCCDA | 1116 | P78527 | |
| DCLEDIQDADCSSSK | 111 | Q9Y2K1 | |
| KCTLCDFAASQEEEL | 301 | O15090 | |
| EKCVDVCSDASRAVD | 336 | Q49AG3 | |
| RCLNCETVSSKDEDF | 181 | P62068 | |
| SCQEEEEFSVLASCL | 1671 | Q6ZT12 | |
| ISSADCNCNVIEIDD | 256 | P0CG32 | |
| CNCNVIEIDDTLDDS | 261 | P0CG32 | |
| SDCEEGLSNVALECS | 596 | Q9ULD9 | |
| CEDCDEAFSFKSNLE | 496 | Q7L2R6 | |
| CKTCEESFALDSELA | 371 | Q96LX8 | |
| ATSCNCKATEDASDL | 871 | Q5TAX3 | |
| CKATEDASDLNDDDN | 876 | Q5TAX3 | |
| DSQAEDSDEDSLCNK | 1646 | Q5T4S7 | |
| DSDEDSLCNKLCTFT | 1651 | Q5T4S7 | |
| DVAKSNTAVCVCNES | 256 | Q5T5U3 | |
| CQDCKDSLSEDLASA | 521 | Q68DK2 | |
| TENCAKEAISDAALE | 876 | Q14966 | |
| IADETKEDICTAQHC | 136 | Q70EL1 | |
| DCKDKSDEENCAVAT | 221 | P01130 |